Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun, Nuriye; KADAYIFÇILAR, SİBEL; Khairallah, Moncef; Lee, Sung; Ozdal, Pinar; Ozyazgan, Yılmaz; Song, Ji; Yu, Hyeong; Lehner, Valerie; de Cordoue, Agnes; Bernard, Oana; Gül, AHMET

doi:10.3109/09273948.2015.1092558

Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., ...More

OCULAR IMMUNOLOGY AND INFLAMMATION, vol.25, no.1, pp.62-70, 2017 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 25 Issue: 1
Publication Date: 2017
Doi Number: 10.3109/09273948.2015.1092558
Journal Name: OCULAR IMMUNOLOGY AND INFLAMMATION
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.62-70
Keywords: Behcet's disease, uveitis, retinal vasculitis, interleukin-1 beta, gevokizumab, XOMA 052, ANTIBODY, INTERLEUKIN-1-BETA
Istanbul University Affiliated: Yes

Abstract

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.